These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 631487)

  • 21. The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol.
    Nies AS; Evans GH; Shand DG
    J Pharmacol Exp Ther; 1973 Mar; 184(3):716-20. PubMed ID: 4631471
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clearance and extraction of radioactive colloidal gold in cirrhotic patients. Their modification by gelatin].
    Lebrec D; Sicot C; Benhamou JP
    Biol Gastroenterol (Paris); 1973; 6(1):41-8. PubMed ID: 4755781
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatic function and portal hemodynamics in patients with liver cirrhosis.
    Kawasaki T; Moriyasu F; Kimura T; Someda H; Tamada T; Yamashita Y; Ono S; Kajimura K; Hamato N; Okuma M
    Am J Gastroenterol; 1990 Sep; 85(9):1160-4. PubMed ID: 2202201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic metabolic function in patients receiving long-term methotrexate therapy: comparison with topically treated psoriatics, patient controls and cirrhotics.
    Birnie GG; Fitzsimons CP; Czarnecki D; Cooke A; Scobie G; Brodie MJ
    Hepatogastroenterology; 1985 Aug; 32(4):163-7. PubMed ID: 2865199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic circulation and drug disposition in cirrhosis.
    Shand DG
    Gastroenterology; 1979 Jul; 77(1):185-6. PubMed ID: 447017
    [No Abstract]   [Full Text] [Related]  

  • 27. Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation.
    Tietge UJ; Bahr MJ; Manns MP; Böker KH
    Liver Transpl; 2001 Dec; 7(12):1015-22. PubMed ID: 11753903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of bioavailability parameters of propranolol in cirrhotic patients after oral administration of the delayed-action form].
    Blanc M; Cales P; Grasset D; Ravaud A; Meskens C; Cotonat J; Pascal JP
    Therapie; 1987; 42(2):187-91. PubMed ID: 3616995
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
    Avram MJ; Krejcie TC; Henthorn TK; Niemann CU
    J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis.
    Kakumitsu S; Shijo H; Yokoyama M; Kim T; Akiyoshi N; Ota K; Kubara K; Okumura M; Inoue K
    Hepatology; 1998 Feb; 27(2):377-82. PubMed ID: 9462634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic value of hepatic clearance of indocyanine green in patients with liver cirrhosis and hemorrhage of esophageal varices].
    Navasa M; García-Pagán JC; Bosch J; Rodés J
    Med Clin (Barc); 1992 Feb; 98(8):290-4. PubMed ID: 1560714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Absorption of vofaverdin by the liver in circulatory insufficiency, chronic hepatitis and liver cirrhosis].
    Fomichev VI
    Klin Med (Mosk); 1973 Oct; 51(10):94-6. PubMed ID: 4787288
    [No Abstract]   [Full Text] [Related]  

  • 33. [Simultaneous, study of systemic and regional visceral hemodynamics in cirrhosis. 3. Systemic and hepatosplanchnic hemodynamics in decompensated liver cirrhosis, with ascites].
    Greco F; Chiandussi L; Sardi G; Vaccarino A; Curti B; Agostoni A; Zardini P; Toscano G
    Minerva Med; 1967 Feb; 58(11):364-7. PubMed ID: 6019271
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
    van Griensven JM; Koster RW; Burggraaf J; Huisman LG; Kluft C; Kroon R; Schoemaker RC; Cohen AF
    Clin Pharmacol Ther; 1998 Jan; 63(1):39-47. PubMed ID: 9465840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The estimation of hepatic blood flow with indocyanine green: comparison between the continuous infusion and single injection methods.
    Villeneuve JP; Huot R; Marleau D; Huet PM
    Am J Gastroenterol; 1982 Apr; 77(4):233-7. PubMed ID: 7072694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (+)-Propranolol clearance, an estimation of hepatic blood flow in man.
    Weiss YA; Safar ME; Lehner JP; Levenson JA; Simon A; Alexandre JM
    Br J Clin Pharmacol; 1978 May; 5(5):457-60. PubMed ID: 656285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic extraction of morphine is impaired in cirrhosis.
    Crotty B; Watson KJ; Desmond PV; Mashford ML; Wood LJ; Colman J; Dudley FJ
    Eur J Clin Pharmacol; 1989; 36(5):501-6. PubMed ID: 2753069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic-hemodynamic interactions in cirrhosis.
    Blei AT
    Semin Liver Dis; 1986 Nov; 6(4):299-308. PubMed ID: 3544223
    [No Abstract]   [Full Text] [Related]  

  • 39. A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol.
    Branch RA; James J; Read AE
    Br J Clin Pharmacol; 1976 Apr; 3(2):243-9. PubMed ID: 973958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration.
    Wood AJ; Kornhauser DM; Wilkinson GR; Shand DG; Branch RA
    Clin Pharmacokinet; 1978; 3(6):478-87. PubMed ID: 719984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.